 It is mainly, though not exclusively, synthesized in the liver and circulates in the bloodstream bound to retinol in a complex with transthyretin.RBP4 has been a drug target for ophthalmology research due to its role in vision.RBP4 may also be involved in metabolic diseases as suggested by recent studies.